DO8

3-deoxy-8-O-phosphono-alpha-D-manno-oct-2-ulopyranosonic acid

Created:	2004-08-18
Last modified:	2020-07-17

Find Related PDB Entry
1 entries where DO8 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	35
Chiral Atom Count	5
Bond Count	35
Aromatic Bond Count	0

2D diagram of DO8

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-deoxy-8-O-phosphono-alpha-D-manno-oct-2-ulopyranosonic acid
Synonyms	3-DEOXY-D-MANNO-2-OCTULOSONATE-8-PHOSPHATE; 3-deoxy-8-O-phosphono-alpha-D-manno-oct-2-ulosonic acid; 3-deoxy-8-O-phosphono-D-manno-oct-2-ulosonic acid; 3-deoxy-8-O-phosphono-manno-oct-2-ulosonic acid
Systematic Name (OpenEye OEToolkits)	(2R,4R,5R,6R)-2,4,5-trihydroxy-6-[(1R)-1-hydroxy-2-phosphonooxy-ethyl]oxane-2-carboxylic acid
Formula	C₈ H₁₅ O₁₁ P
Molecular Weight	318.172
Type	D-SACCHARIDE, ALPHA LINKING

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=P(O)(O)OCC(O)C1OC(O)(C(=O)O)CC(O)C1O
SMILES	CACTVS	3.341	O[CH](CO[P](O)(O)=O)[CH]1O[C](O)(C[CH](O)[CH]1O)C(O)=O
SMILES	OpenEye OEToolkits	1.5.0	C1C(C(C(OC1(C(=O)O)O)C(COP(=O)(O)O)O)O)O
Canonical SMILES	CACTVS	3.341	O[C@H](CO[P](O)(O)=O)[C@H]1O[C@](O)(C[C@@H](O)[C@H]1O)C(O)=O
Canonical SMILES	OpenEye OEToolkits	1.5.0	C1[C@H]([C@H]([C@H](O[C@]1(C(=O)O)O)[C@@H](COP(=O)(O)O)O)O)O
InChI	InChI	1.03	InChI=1S/C8H15O11P/c9-3-1-8(14,7(12)13)19-6(5(3)11)4(10)2-18-20(15,16)17/h3-6,9-11,14H,1-2H2,(H,12,13)(H2,15,16,17)/t3-,4-,5-,6-,8-/m1/s1
InChIKey	InChI	1.03	IZZNRKJLBIYBJN-HXUQBWEZSA-N

Related Resource References

Resource Name	Reference
PubChem	4369556
ChEBI	CHEBI:42115

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.